Castle Biosciences, Inc. Common Stock (CSTL) is a publicly traded Healthcare sector company. As of May 21, 2026, CSTL trades at $19.96 with a market cap of $585.97M and a P/E ratio of -23.44. CSTL moved +4.35% today. Year to date, CSTL is -48.64%; over the trailing twelve months it is +21.39%. Its 52-week range spans $14.59 to $44.28. Analyst consensus is strong buy with an average price target of $44.40. Rallies surfaces CSTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CSTL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CSTL recently traded at $19.96. Market cap is $585.97M. P/E ratio is -23.44. Revenue is $344.23M.
| Metric | Value |
|---|---|
| Price | $19.96 |
| Market Cap | $585.97M |
| P/E Ratio | -23.44 |
| EPS | $-0.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.28 |
| 52-Week Low | $14.59 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $344.23M |
| Net Income | $-24.16M |
| Gross Margin | 79.37% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $344.23M | $-24.16M | $-0.83 |
| 2023 | $219.79M | $-57.47M | $-2.14 |
| 2022 | $137.04M | $-67.14M | $-2.58 |
| 2021 | $94.08M | $-31.29M | $-1.24 |
5 analysts cover CSTL: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $44.40.